Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.
| Website: | www.alkermes.com |
| Email: | financial@alkermes.com |
| Main Phone: | +353 17728000 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House |
| City / Town: | Dublin |
| Country: | IRL |
| Postal Code: | 4 |
| Exchange: | NGS |
| CEO: | Richard F. Pops |
| Employees: | 2000 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 42.10 | Change $ 0.54 | Change % 1.30 | Tick N/A |
| Bid 42.09 | Bid Size 700.00 | Ask 42.13 | Ask Size 200.00 |
| Open 41.55 | High 42.11 | Low 41.45 | Prev Close 41.56 |
| Last Trade | Volume 175,094 | 52 Wk Hi 71.22 | 52 Wk Low 38.23 |
| Market Cap 6.5 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 155,315,178.00 | EPS (TTM) -0.91 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 26 | 147 |
| Number of Buys | 11 | 73 |
| Number of Sells | 15 | 74 |
| Net Activity | -15686 | 139596 |
| Last 10 Buys | Shares |
|---|---|
| David W. Anstice | 1,000 |
| Wendy L. Dixon | 1,000 |
| Mark Stejbach | 1,000 |
| Floyd E Bloom | 1,000 |
| David W. Anstice | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| James M. Frates | 1,000 |
| Paul J. Mitchell | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Michael J. Landine | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 67 | 67 | 67 | 67 |
| Low Target Price Estimate | 46 | 46 | 46 | 46 |
| Mean Target Price Estimate | 56.13 | 55.57 | 55.57 | 56.13 |
| Standard Deviation | 7.32 | 7.72 | 7.72 | 7.32 |
| Date of Most Recent Estimate | 06/06/18 | 05/22/18 | 05/22/18 | 06/06/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| CT ORDER | 1 | 2018-05-30 | |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 4 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2.11 | 2.43 | 2.33 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
